Epidermal growth factor receptor T790M mutation-positive metastatic non-small-cell lung cancer: focus on osimertinib (AZD9291)

Adenocarcinoma is the most common type of non-small-cell lung cancer (NSCLC). Adenocarcinoma with epidermal growth factor receptor (EGFR) mutations accounts for 8%–30% of all cases of NSCLC depending on the geography and ethnicity. EGFR-mutated NSCLC usually responds to first-line therapy with EGFR...

Descripción completa

Detalles Bibliográficos
Autores principales: Saad, Nibal, Poudel, Aarati, Basnet, Alina, Gajra, Ajeet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370386/
https://www.ncbi.nlm.nih.gov/pubmed/28367058
http://dx.doi.org/10.2147/OTT.S100650

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5370386/
https://www.ncbi.nlm.nih.gov/pubmed/28367058
http://dx.doi.org/10.2147/OTT.S100650

Ejemplares similares